| Latest | F'cast | |
|---|---|---|
| Div Yield | 0.0% | 0.0% |
| Div Cover | n/a | n/a |
| Op Mrgn | -7041.2% | n/a |
| ROCE | n/a |
| Latest | F'cast | |
|---|---|---|
| P/E | n/a | n/a |
| PEG | n/a | n/a |
| Pr/Revenue | 16.0 | n/a |
| Pr/Book | 0.2 |
| Latest | F'cast | |
|---|---|---|
| Revenue | 500.0% | n/a |
| PBT | n/a | n/a |
| EPS | n/a | n/a |
| DPS | n/a | n/a |
| Year Ending | Revenue ($m) | Pre-tax ($m) | EPS | P/E | PEG | EPS Grth. | Div | Yield |
|---|---|---|---|---|---|---|---|---|
| 31-Dec-20 | n/a | (0.76) | (1.00)¢ | n/a | n/a | n/a | n/a | 0.0% |
| 31-Dec-21 | 0.03 | (5.90) | (0.04)¢ | n/a | n/a | n/a | n/a | 0.0% |
| 31-Dec-22 | 0.02 | (8.81) | (0.05)¢ | n/a | n/a | n/a | n/a | 0.0% |
| 31-Dec-23 | 0.02 | (6.34) | (4.00)¢ | n/a | n/a | n/a | n/a | 0.0% |
| 31-Dec-24 | 0.11 | (7.78) | (5.00)¢ | n/a | n/a | n/a | n/a | 0.0% |
a. Based on UK GAAP presentation of accounts - includes discontinued activities
| Issue of Equity - Conversion of Loan Notes | 10-Mar-2026 | 07:00 | RNS |
| Holding(s) in Company | 10-Mar-2026 | 07:01 | RNS |
| Proposed issue of Secured Convertible Loan Notes | 30-Dec-2025 | 17:00 | RNS |
| Issue of Equity - Conversion of Loan Notes | 10-Mar-2026 | ShareCast |
| Holding(s) in Company | 10-Mar-2026 | ShareCast |
| Trellus Health reports operational, commercial p... | 03-Feb-2026 | ShareCast |
No deals were found in the last 28 days.
| Currency | UK Pounds |
| Share Price | 0.18p |
| Change Today | 0.000p |
| % Change | 0.00 % |
| 52 Week High | 1.85 |
| 52 Week Low | 0.15 |
| Volume | 6,240,017 |
| Shares Issued | 322.33m |
| Market Cap | £0.56m |
| Beta | 0.00 |
| Value |
|
|---|
| Price Trend |
|
|---|
| Income | ![]() |
|---|
| Growth |
|
|---|
| No dividends found |
| Time | Volume / Share Price |
| 16:06 | 324,811 @ 0.18p |
| 15:58 | 120,734 @ 0.17p |
| 15:35 | 1,300 @ 0.20p |
| 15:02 | 100,755 @ 0.17p |
| 14:47 | 440,000 @ 0.18p |
You are here: research